Dimensional Fund Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Sell |
92,134
-216,096
| -70% | -$8.75M | ﹤0.01% | 2605 |
|
|
2025
Q1 | $15.8M | Sell |
308,230
-33,075
| -10% | -$1.7M | ﹤0.01% | 2052 |
|
|
2024
Q4 | $18.9M | Sell |
341,305
-62,658
| -16% | -$3.47M | ﹤0.01% | 2014 |
|
|
2024
Q3 | $13.3M | Sell |
403,963
-2,936
| -0.7% | -$96.6K | ﹤0.01% | 2178 |
|
|
2024
Q2 | $11.1M | Sell |
406,899
-17,931
| -4% | -$487K | ﹤0.01% | 2218 |
|
|
2024
Q1 | $15.4M | Sell |
424,830
-5,297
| -1% | -$193K | ﹤0.01% | 2117 |
|
|
2023
Q4 | $8.71M | Buy |
430,127
+74,444
| +21% | +$1.51M | ﹤0.01% | 2375 |
|
|
2023
Q3 | $6.32M | Buy |
355,683
+99,223
| +39% | +$1.76M | ﹤0.01% | 2451 |
|
|
2023
Q2 | $4.63M | Buy |
256,460
+20,930
| +9% | +$378K | ﹤0.01% | 2553 |
|
|
2023
Q1 | $2.96M | Buy |
235,530
+35,854
| +18% | +$451K | ﹤0.01% | 2635 |
|
|
2022
Q4 | $2.93K | Buy |
199,676
+57,469
| +40% | +$842 | ﹤0.01% | 2607 |
|
|
2022
Q3 | $2.43M | Buy |
142,207
+29,232
| +26% | +$500K | ﹤0.01% | 2652 |
|
|
2022
Q2 | $1.65M | Buy |
112,975
+84,120
| +292% | +$1.23M | ﹤0.01% | 2797 |
|
|
2022
Q1 | $485K | Buy |
28,855
+19,865
| +221% | +$334K | ﹤0.01% | 3158 |
|
|
2021
Q4 | $202K | Buy |
+8,990
| New | +$202K | ﹤0.01% | 3342 |
|